Abbott/Biocompatibles
This article was originally published in The Gray Sheet
Executive Summary
Firms forge multi-year agreement for Abbott to exclusively distribute Biocompatibles' BiodivYsio coated stent products in the U.S. Abbott also gains rights to Biocompatibles' pipeline of other interventional vascular products and an option to license proprietary phosphorylcholine (PC) coating technology for other Abbott vascular devices worldwide. The PC coating is designed to improve performance, reduce restenosis and thrombosis. A U.S. regulatory filing for the stent will be submitted by Biocompatibles by year-end